Shilpa Pharma Lifesciences Recognized with EcoVadis Gold Medal
Shilpa Pharma Lifesciences Limited has recently achieved a remarkable milestone by receiving the esteemed EcoVadis Gold Medal, awarded by the world's most recognized provider of sustainability ratings. This accolade emphasizes the dedication of the company towards sustainable practices that are vital in today's pharmaceutical landscape.
Outstanding Sustainability Performance
With an impressive score of 82 out of 100, Shilpa Pharma placed itself in the 98th percentile among over 130,000 companies assessed by EcoVadis. This significant achievement highlights the company's commitment to outstanding Environmental, Social, and Governance (ESG) practices, reinforcing their position as a responsible player in the global pharmaceutical industry.
EcoVadis Assessment Criteria
EcoVadis evaluates companies based on four critical pillars: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement. Shilpa Pharma's strong performance across these categories demonstrates their commitment to ethical operations and sustainable business practices. This recognition places Shilpa among the elite companies globally that are taking significant strides towards sustainable operations.
Leadership Voices on Sustainability
Mr. Keshav Bhutada, Executive Director and CEO of Shilpa Pharma Lifesciences, commented on this achievement, stating, "Sustainability and innovation are integral to our growth strategy, as we collaborate with international innovators on their New Chemical Entity programs. The EcoVadis Gold Medal confirms our dedicated efforts toward responsible manufacturing and ethical governance that ultimately benefit patients and our partners. We are eager to collaborate with more global innovator companies. "
Sustaining Partnerships Through Trust
This recognition not only enhances Shilpa's reputation among global customers, investors, and partners but also solidifies their standing as a reliable contract development and manufacturing organization (CDMO). Their commitment to sustainable practices places them as a preferable partner in the global market.
About Shilpa Medicare Limited
Shilpa Medicare Limited is a prominent Indian pharmaceutical company dedicated to the development, production, and marketing of active pharmaceutical ingredients (APIs), formulations, and biologics in oncology, infectious diseases, and specialized segments. With a focus on complex generics and innovative drug delivery systems, Shilpa caters to markets in over 80 countries, making a significant impact on patient care worldwide.
Frequently Asked Questions
What is the EcoVadis Gold Medal?
The EcoVadis Gold Medal is a prestigious recognition awarded to companies that demonstrate exceptional sustainability practices across various operational pillars.
How did Shilpa Pharma achieve this recognition?
Shilpa Pharma scored 82 out of 100 in the EcoVadis assessment, placing them in the top 2% of over 130,000 companies evaluated for their sustainability practices.
What are the key criteria assessed by EcoVadis?
EcoVadis evaluates companies based on Environment, Labor & Human Rights, Ethics, and Sustainable Procurement measures.
What impact does this recognition have on Shilpa Pharma?
This accolade enhances Shilpa Pharma's reputation globally, attracting more partnerships and reinforcing trust among customers and investors.
What sectors does Shilpa Medicare Limited focus on?
Shilpa Medicare Limited primarily focuses on oncology, infectious diseases, and specialty segments, producing APIs and formulations, along with offering CDMO services.
